About This Educational Activity

Title: You and Lung Cancer – An Animated Patient's Guide to Lung Cancer
Launch date: November 1, 2017
Primary support from: Bristol-Myers Squibb Foundation Inc. and Celgene

Title: You and Lung Cancer – New Module on Immunotherapy for Lung Cancer
Launch date: August 10, 2020
Primary support from: Bristol-Myers Squibb Grants and Giving and Celgene
Additional support from: AstraZeneca and Genentech

Title: You and Lung Cancer – New Module on Biomarker Testing in Non-small Cell Lung Cancer
Launch date: May 20, 2021
Primary support from: Bristol-Myers Squibb Grants and Giving and Foundation Medicine
Additional support from: Novartis, Genentech, and Pfizer

Title: You and Lung Cancer – New Modules on Clinical Trials in Lung Cancer
Launch date: September 1, 2022
Primary support from: Merck Sharp & Dohme LLC, Pfizer, Neogenomics, Bristol-Myers Squibb Grants and Giving, and Novartis
Additional support from: Genentech and Foundation Medicine

Title: You and Lung Cancer – New Modules on Screening for Lung Cancer
Launch date: May 30, 2023
Primary support from: Bristol-Myers Squibb Grants and Giving, Genentech, and Merck Sharp & Dohme LLC
Additional support from: Jazz Pharmaceuticals and Takeda Oncology

Title: You and Lung Cancer – New Modules on Common Biomarkers in NSCLC – Understanding Your Mutation
Launch date: May 14, 2024
Primary support from: Bristol-Myers Squibb Grants and Giving, Merck Sharp & Dohme LLC, Novartis, and Pfizer
Additional support from: Foundation Medicine

This educational activity has been developed by A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc, with the assistance of several Faculty, who are experts in lung cancer (See Authors).

The Animated Patient’s Guide to Lung Cancer (YouAndLungCancer.com) resource provides easy-to-understand and expert-approved animations, expert video explanations, patient story interviews and infographics to help patients discuss key issues with their healthcare provider and make important decisions related to management and treatment of lung cancer.

Outline of Program

The Educational content is divided into six (6) patient learning modules:

1. Understanding Lung Cancer 
• Understanding Non-Small Cell Lung Cancer (NSCLC)
• Understanding Small Cell Lung Cancer (SCLC)
2. Screening for Lung Cancer
• Screening for Lung Cancer
• Lung Cancer Screening for Black Americans
• Lung Cancer Screening for Native Americans
3. Diagnosing Lung Cancer 
• Diagnosis and Screening of Lung Cancer
• Staging of Lung Cancer
• Understanding Biomarker Testing in Non-Small Cell Lung Cancer
4. Treating Lung Cancer 
• Treatment and Management of Lung Cancer
• Immunotherapy for Lung Cancer
• Targeted Therapy in Non-Small Cell Lung Cancer
5. Clinical Trials in Lung Cancer 
• Understanding Clinical Trials in Lung Cancer
• Lung Cancer Clinical Trials and the US Black Community
• Lung Cancer Clinical Trials and Native Americans
6. Common Biomarkers in NSCLC
• NSCLC Treatment When You Have an EGFR Mutation
• NSCLC Treatment When You Have a KRAS Mutation
• NSCLC Treatment for Less Common Mutations: ALK, BRAF, ROS1, HER2, MET
• Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers

Learning Objectives of this Educational Program:

• To enhance communications between lung cancer patients and their healthcare providers by increasing patient understanding of the complexities of the disease, the risks, staging, and clinical prognosis.
• To provide patients and healthcare providers with an understanding of disease management strategies and interventions, available therapeutic options, and associated clinical outcomes.
• To strengthen the patient-provider partnership by enhancing the decision-making process through an explanation of the risks and benefits and patient informed consent, to allow for collaborative decision making.

Disclaimer

By using this website you agree to the Terms of Use.

This Website is intended for patients, caregivers, and health care professionals within the United States.

The opinions expressed in this Website are those of the contributing faculty authors, and are not those of the producer and publisher, Mechanisms in Medicine Inc.

Participants have an implied responsibility to use the newly acquired information to enhance their own personal development and health.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should be discussed with your physician.

The information presented in this activity is not meant to serve as a guideline for patient management, nor should it substitute for the medical advice from your physician or healthcare professional.

This website is part of the Animated Patient^® series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.

This website was originally launched on November 1, 2017.

Disclosure of Conflicts of Interest

Instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI).

See Authors for a list of Authors and their Conflict of Interest disclosures.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.

The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Technical Requirements

You and Lung Cancer – The Animated Lung Cancer Patient is an internet-based educational program available on Mac and PC. Click here to view Technical Requirements.